Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.7, n°5-6 - May-June 2015
Paru le :
01/05/2015
Année
2015
Page(s) :
349-554
Langue(s) :
Anglais
Note de contenu :
SELECTION :
- Cannabinoid findings in children hair - what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Delta9-tetrahydrocannabinolic acid A concentrations. Moosmann B., Roth N., Hastedt M., Jacobsen-Bauer A., Pragst F., Auwärter V., p. 349-357.
- Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Wallach J., Kavanagh P.V., McLaughlin G., Morris N., Power J.D., Elliott S.P., et al., p. 358-367.
- Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MSn standard screening approaches. Helfer A.G., Turcant A., Boels D., Ferec S., Lelièvre B., Welter J., et al., p. 368-375.
- Determination of GHB in human hair by HPLC-MS/MS: Development and validation of a method and application to a study group and three possible single exposure cases. Bertol E., Mari F., Vaiano F., Romano G., Zaami S., Baglìo G., et al., p. 376-384.
- Qualitative analysis of seized cocaine samples using desorption electrospray ionization- mass spectrometry (DESI-MS). Stojanovska N., Tahtouh M., Kelly T., Beavis A., Fu S., p. 393-400.
- Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study. Riba J., McIlhenny E.H., Bouso J.C., Barker S.A., p. 401-406.
- Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine. Sundström M., Pelander A., Ojanperä I., p. 420-427.
- Chemiluminescence detection of MDMA in street drug samples using tris(2,2'-bipyridine)ruthenium(III). Theakstone A.G., Smith Z.M., Terry J.M., Barnett N.W., Francis P.S., p. 428-432.
- Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Archer J.R.H., Dargan P.I., Lostia A.M., van der Walt J., Henderson K., Drake N., et al., p. 433-438.
- Pyrolysis of drugs of abuse: a comprehensive review. Bell S., Nida C., p. 445-456.
- Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids. Spinelli E., Barnes A.J., Young S., Castaneto M.S., Martin T.M., Klette K.L., et al., p. 467-474.
- Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens. Castaneto M.S., Scheidweiler K.B., Gandhi A., Wohlfarth A., Klette K.L., Martin T.M., et al., p. 483-493.
- Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Lee D., Vandrey R., Mendu D.R., Murray J.A., Barnes A.J., Huestis M.A., p. 494-501.
- The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography - tandem mass spectrometry. Patteet L., Maudens K.E., Stove C.P., Lambert W.E., Morrens M., Sabbe B., et al., p. 502-511.
- Cannabinoid findings in children hair - what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Delta9-tetrahydrocannabinolic acid A concentrations. Moosmann B., Roth N., Hastedt M., Jacobsen-Bauer A., Pragst F., Auwärter V., p. 349-357.
- Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Wallach J., Kavanagh P.V., McLaughlin G., Morris N., Power J.D., Elliott S.P., et al., p. 358-367.
- Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MSn standard screening approaches. Helfer A.G., Turcant A., Boels D., Ferec S., Lelièvre B., Welter J., et al., p. 368-375.
- Determination of GHB in human hair by HPLC-MS/MS: Development and validation of a method and application to a study group and three possible single exposure cases. Bertol E., Mari F., Vaiano F., Romano G., Zaami S., Baglìo G., et al., p. 376-384.
- Qualitative analysis of seized cocaine samples using desorption electrospray ionization- mass spectrometry (DESI-MS). Stojanovska N., Tahtouh M., Kelly T., Beavis A., Fu S., p. 393-400.
- Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study. Riba J., McIlhenny E.H., Bouso J.C., Barker S.A., p. 401-406.
- Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine. Sundström M., Pelander A., Ojanperä I., p. 420-427.
- Chemiluminescence detection of MDMA in street drug samples using tris(2,2'-bipyridine)ruthenium(III). Theakstone A.G., Smith Z.M., Terry J.M., Barnett N.W., Francis P.S., p. 428-432.
- Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Archer J.R.H., Dargan P.I., Lostia A.M., van der Walt J., Henderson K., Drake N., et al., p. 433-438.
- Pyrolysis of drugs of abuse: a comprehensive review. Bell S., Nida C., p. 445-456.
- Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids. Spinelli E., Barnes A.J., Young S., Castaneto M.S., Martin T.M., Klette K.L., et al., p. 467-474.
- Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens. Castaneto M.S., Scheidweiler K.B., Gandhi A., Wohlfarth A., Klette K.L., Martin T.M., et al., p. 483-493.
- Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Lee D., Vandrey R., Mendu D.R., Murray J.A., Barnes A.J., Huestis M.A., p. 494-501.
- The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography - tandem mass spectrometry. Patteet L., Maudens K.E., Stove C.P., Lambert W.E., Morrens M., Sabbe B., et al., p. 502-511.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
S. BELL ;
C. NIDA
|
2015
Dans Drug Testing and Analysis (Vol.7, n°5-6, May-June 2015) Article : Périodique
Dans Drug Testing and Analysis (Vol.7, n°5-6, May-June 2015) Article : Périodique
This review summarizes the literature to date relating to pyrolysis and heated vapour ingestion of drugs of abuse. In this context, heating is referred to as smoking or pyrolysis, but these are generic descriptors that encompass numerous methods[...]